Kaminari Medical utilizes photoacoustic imaging to detect coronary artery disease by analyzing the sound generated from light interacting with arterial plaque. This technology enhances the accuracy of coronary revascularization procedures, improving patient outcomes in cardiovascular care.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Coronary artery disease detection often relies on invasive procedures or imaging techniques with limited resolution, hindering accurate assessment of arterial plaque composition and stability. Current methods may not effectively differentiate between stable and vulnerable plaques, potentially leading to suboptimal treatment decisions during coronary revascularization.
Solution
Kaminari Medical employs photoacoustic imaging, a non-invasive technology, to visualize and characterize coronary artery disease by analyzing the acoustic signals generated when light interacts with arterial plaque. This approach allows for enhanced visualization of plaque morphology and composition, potentially differentiating between stable and unstable plaques. By providing detailed information about plaque characteristics, Kaminari Medical's technology aims to improve the accuracy and effectiveness of coronary revascularization procedures, leading to better patient outcomes in cardiovascular care. The technology offers a novel way to "hear" the impact of light on plaque, providing clinicians with a more comprehensive understanding of the disease state.
Target Audience
The primary target audience includes interventional cardiologists, cardiovascular surgeons, and hospitals specializing in cardiac care.
Features
- Photoacoustic imaging for non-invasive visualization of coronary arteries.
- Differentiation of stable versus unstable plaque based on acoustic signatures.
- High-resolution imaging of plaque morphology and composition.
- Integration with existing coronary revascularization procedures.